Work

Advancing MET-aberrant NSCLC Therapy with Glumetinib: Pharmacokinetics, Efficacy, Safety, Drug Interactions, and Clinical Prospects

Year: 2026

Type: article

Source: Current Drug Metabolism

DOI: 10.2174/0113892002428815251201090233

Authors: Ming Lu, Xiaoyu Yin, Zhiqing Zhang

Institutions: Hebei Medical University, Second Hospital of Hebei Medical University, Hebei General Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7158544343

FWCI:

Cites: 98

Cited by:

Related to: